Search Results 1-10 of 28404 for ���������������������������op������r���:za33���
... OP, Ho AC, Kuriyan AE, Yonekawa Y, Starr MR. Neurotrophic keratopathy following rhegmatogenous retinal detachment surgery. Can J Ophthalmol. 2023 Jun 14 ...
Targeted drug therapies have greatly improved outcomes for patients with relapsed or refractory (R/R) chronic lymphocytic leukemia (CLL) and non-Hodgkin's ...
It is also used to temporarily treat itching of the eye caused by a condition known as seasonal allergic conjunctivitis. This medicine belongs to the group of ...
Brinzolamide ophthalmic (eye) drops is used to treat increased pressure in the eye caused by open-angle glaucoma or a condition called ocular hypertension. Both ...
Polatuzumab vedotin-piiq injection is used together with other cancer medicines (eg, bendamustine, rituximab) to treat diffuse large B-cell lymphoma (DLBCL) ...
Klatte DCF, Starr JS, Clift KE, Hardway HD, van Hooft JE, van Leerdam ME, Potjer TP, Presutti RJ, Riegert-Johnson DL, Wallace MB, Bi Y. Utilization and ...
Zayat R, Fermo OP. Two cases of delayed onset, fully reversible cortical oedema and signal intensity on brain MRI without infarction caused by prolonged ...
The purpose of this study is to compare the effectiveness and safety of the humanized monoclonal anti CD19 antibody tafasitamab plus lenalidomide in addition to ...
Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and ...
This Phase 2, two-arm, open-label study is designed to evaluate the safety, clinical activity, predictive biomarkers and pharmacokinetics/ pharmacodynamics of ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Your gift can go twice as far to advance cancer research and care!